2 completed, 1 terminated, 1 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Terminated 1, Unknown 1 |
Follow Shingles: new trials by email Literature Review of Shingles trials Research Report on Shingles
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients recombinant zoster vaccine - Shingles, Zoster | Phase 4 | Unknown | Prof Patrice Lalive | 100 | 2022-12-01 | 2024-04-10 |
| Immune Response to Shingles Vaccination Zoster Vaccine Live - Shingles | Phase 4 | Completed | University of Washington | 10 | 2016-02-01 | 2019-12-05 |
| ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors ZOSTAVAX - Shingles | Phase 4 | Terminated | Louis Stokes VA Medical Center | 22 | 2015-05-01 | 2026-09-23 |
| ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034) Zoster Vaccine Live - Herpes Zoster, Shingles | Phase 4 | Completed | Merck Sharp & Dohme LLC | 180 | 2012-04-01 | 2017-04-12 |
Herpes Zoster (4) · Multiple Sclerosis (1)
DNA Virus Infections (4) · Herpesviridae Infections (4) · Infections (4) · Varicella Zoster Virus Infection (4) · Virus Diseases (4) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Immune System Diseases (1) · Nervous System Diseases (1)
Louis Stokes VA Medical Center (1) · Merck Sharp & Dohme LLC (1) · Prof Patrice Lalive (1) · University of Washington (1)
Switzerland (1) · United States (1)
Arnaud Didierlaurent, Pr (1) · David H. Canaday, MD (1) · Patrice Lalive, Pr (1)